|
|
41
|
|
|
B4613
|
|
|
DAPAGLIFLOZIN|METFORMIN 5MG|1G TAB (KWA)
|
|
|
DAPAGLIFLOZIN|METFORMIN
|
|
|
DAPAGLIFLOZIN|METFORMIN
|
|
|
30'S
|
|
|
A
|
|
|
8.32
|
|
|
0.2773
|
|
|
5MG|1G
|
|
|
TAB
|
|
|
30
|
|
|
BOX
|
|
|
KWA
|
|
|
KWALITY PHARMACEUTICALS
|
|
|
ATB
|
|
|
ANSA TRADING BARBADOS LTD
|
|
|
B
|
|
|
Anti-Diabetic
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
N
|
|
|
682018
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|